Advertisement

The Latest

Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, which is designed for patients with degenerative disc disease. Triadyme-C has…

AI and automation are everywhere, and for healthcare leaders, especially those in pharmacy, the pressure to “do more with less” has never been greater. Many teams know AI and automation solutions hold promise to increase efficiency, maximize revenue, or improve…

In this episode, Andrew DeVoe, Executive Vice President and CFO of Tufts Medicine, shares how the organization reversed a $300 million loss run rate to profitability in just over a year. He outlines key cost-saving strategies, revenue cycle improvements, and…

Kim Spencer, PharmD, St. Louis-based SSM Health’s chief pharmacy officer, has stepped down from her role.  Dr. Spencer, who built and oversaw a team of 1,400 pharmacy professionals, said in a July 7 LinkedIn that the post was “the honor…

This episode features Paige Twenter, Assistant Editor at Becker’s Hospital Review, sharing insights on two major developments in healthcare. She discusses the Joint Commission’s sweeping reduction of hospital standards and the recent court rulings that reinstated billions in NIH research…

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, University of Rochester (N.Y.) Wilmot Cancer Institute and New York City-based Mount Sinai, NYU Langone Health and Weill Cornell Medicine have established the Empire State Cellular Therapy Consortium. Member organizations will have expanded…

Advertisement